x
Loading...
Sysmex Europe GmbH
Bornbarch 1
22848 Norderstedt
Phone: +49 (40) 527 26 0
Fax: +49 (40) 527 26 100
info@sysmex-europe.com
Want to leave us a message or have us call you back? Use our Email Contact-Form!
x
FIT screening
Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.
Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.
Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients
Press releases
Here´s your quick access to our latest press releases.
Sysmex to Be Special Sponsor of the Kobe Marathon 2019
With a View to New Value Creation, Sysmex Launches a Research Assay Service for HDL Function Measurement
Sysmex Launches Revohem FIX Chromogenic, a Blood Coagulation Factor IX Measurement Kit
Sysmex and MolecularMD Commence Global Partnership to Address the Challenges in Companion Diagnostics Development and Commercialization
CALiaGold – The new quantitative immunoassay from Sentinel Diagnostics for calprotectin measurement in SENTiFIT 270 Analyser
Sysmex Inostics OncoBEAM™ circulating tumor DNA technology demonstrates superior response prediction for advanced pancreatic cancer over standard-of-care protein biomarkers
Strengthening Our Global R&D Structure to Foster Early-Stage Innovation
Sysmex Inostics´ OncoBEAM™ platform demonstrates superior detection of clinically-relevant mutations for therapy selection and molecular monitoring for lung and colon cancers
In vitro diagnostics company Sysmex Europe announces executive leadership change
Sysmex Inostics announces launch of OncoBEAM™ EGFR Kit v2 (RUO) in Europe and Asia
